Breakthrough nanovaccine uses tumor cell membranes and immune-boosting polymers to enhance personalized cancer immunotherapy, ...

GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, today announced that Dr. Kristopher Wentzel ...

Alternatively, food antigen presentation from tDC led to an anti ... Additionally, tDC shares epigenetic profiles with classical dendritic cells, a type of antigen-presenting cell (APC) that ...

The analysis was included in a presentation ... dendritic cells combined with RNA and proteins prepared from a sample of their tumor. This unique approach allows targeting of the complete cancer ...

Liquid biopsy-based prediction of clinical benefit from immune checkpoint inhibitors in advanced biliary tract cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...

Abnormal dendritic cell activation and presentation of self-antigens may contribute to autoimmune diseases like rheumatoid arthritis, lupus erythematosus, autoimmune myocarditis, psoriasis, multiple ...

Dendritic cells are immune cells that capture and ... In contrast, the treatment of BMDCs with valeric acid enhanced their antigen presentation ability. It was also observed that SCAFs activated ...

dendritic cells, antigen presentation, Major Histocompatibility Complex, and more. He was previously affiliated with NIH National Cancer Institute, USA and Mukogawa Women's University, and has ...

This is because dendritic cells have an ER with a particularly ... "This would make antigen presentation far more efficient." The hope now is that these findings will help in the development ...

Dendritic cells influence several factors in HIV infection including viral transmission, the targeting of infected cells and presentation of the HIV antigens. Through cytokine and interferon ...

such as macrophages and B cells, are also involved in antigen presentation, DCs are versatile because of their ability to “cross present.” Dendritic cells can present extracellular antigens on ...

In addition to direct and cross‐presentation, dendritic cells (DCs) can present tumor antigens (TAs) to T cells via a hitherto poorly understood mechanism called “cross‐dressing.” DC cross‐dressing ...